title: The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans.
abstract: To investigate the predictive value of minor salivary gland biopsy in clinically diagnosed early stage Parkinson's disease (PD) patients, and to provide more evidence of minor salivary gland biopsy as a pathological diagnostic biomarker of PD. Thirteen patients with early stage PD and 13 age-matched controls were recruited. Hoehn and Yahr stage and Unified Parkinson's disease Rating Scale Part III were employed to evaluate their severity of the disease. All the subjects underwent minor salivary gland biopsy and (11)C-methyl-N-2β-carbomethoxy-3β-(4-fluorophenyl) tropane ((11)C-CFT) DAT-PET scan. Immunohistochemical staining for Lewy-type alpha-synucleinopathy using antibody against alpha-synuclein (α-Syn) was performed in the tissues obtained from minor salivary gland. Abnormal accumulation of α-Syn was found around the gland cells in 9 of the 13 patients with PD, but in none of the control subjects. The α-Syn immunoreactive structures were located in the periacinar space. Twelve clinically diagnosed PD patients showed asymmetrical and relatively severe reduction of (11)C-CFT uptake in the posterior putamen compared with the control. The sensitivity, specificity, positive predictive value and negative predictive value of minor salivary gland biopsy were 75, 100, 100 and 25%, respectively, when compared with the DAT-PET imaging. Our results suggest that minor salivary gland biopsy does not hold high diagnostic accuracy as DAT-PET, but still has the potential to be a useful pathologic biomarker for PD, which is worth more investigations.
authors.affiliation: Center for Neurodegenerative Diseases, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing, 100050, China.
authors.forename: Liyan
authors.initials: L
authors.lastname: Gao
authors.forename: Huimin
authors.initials: H
authors.lastname: Chen
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.forename: Fangfei
authors.initials: F
authors.lastname: Li
authors.forename: Qiaohong
authors.initials: Q
authors.lastname: Ou-Yang
authors.forename: Tao
authors.initials: T
authors.lastname: Feng
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D001931:Brain Mapping; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D049268:Positron-Emission Tomography; D012470:Salivary Glands, Minor / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D051844:alpha-Synuclein / Q000378:metabolism
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; C497604:SNCA protein, human; D051844:alpha-Synuclein
references.citation: J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
references.pmid: 1564476
references.citation: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S38-40
references.pmid: 20123555
references.citation: Neuroscience. 2007 Mar 16;145(2):539-55
references.pmid: 17275196
references.citation: Acta Neuropathol. 2010 Jun;119(6):703-13
references.pmid: 20229352
references.citation: Neurosci Lett. 2005 Jun 24;381(3):294-8
references.pmid: 15896487
references.citation: Neurosci Lett. 2014 Oct 17;582:99-103
references.pmid: 25218716
references.citation: Transl Neurodegener. 2013 Aug 07;2(1):16
references.pmid: 23919415
references.citation: Eur J Neurol. 2008 Apr;15 Suppl 1:14-20
references.pmid: 18353132
references.citation: Mov Disord. 2011 Jan;26(1):188-90
references.pmid: 20836135
references.citation: Lancet Neurol. 2009 Dec;8(12):1150-7
references.pmid: 19909913
references.citation: Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1594-603
references.pmid: 20107789
references.citation: Mov Disord. 2008 Aug 15;23(11):1608-12
references.pmid: 18649394
references.citation: Brain Res Bull. 2009 Feb 16;78(2-3):105-8
references.pmid: 18790022
references.citation: Neurosci Lett. 2010 Jan 29;469(3):357-9
references.pmid: 20026177
references.citation: Mov Disord. 2012 May;27(6):709-15
references.pmid: 21766334
references.citation: Front Psychiatry. 2010 Sep 03;1:128
references.pmid: 21423439
references.citation: Eur J Neurosci. 2008 Feb;27(4):947-57
references.pmid: 18333965
references.citation: Neurogastroenterol Motil. 2012 Apr;24(4):e202-5
references.pmid: 22292943
references.citation: PLoS One. 2010 Sep 14;5(9):e12728
references.pmid: 20856865
references.citation: Arthritis Rheum. 2008 May 15;59(5):714-20
references.pmid: 18438907
references.citation: Neurosci Lett. 2013 Sep 13;551:62-4
references.pmid: 23880024
references.citation: J Neuropathol Exp Neurol. 2013 Feb;72(2):130-6
references.pmid: 23334596
references.citation: Lancet Neurol. 2010 Feb;9(2):149-58
references.pmid: 20061183
references.citation: Gut. 2008 Dec;57(12):1741-3
references.pmid: 19022934